WindMIL Therapeutics
PrivateLast Round
Series B
Jun 18, 2018
Total Funding Raised
$43.5M
Company Overview
WindMIL Therapeutics is a biotechnology company that develops autologous cell therapies based on marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WindMIL Therapeutics Comparables
Compare WindMIL Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Triumvira Immunologics | 81% | |
| Marker Therapeutics Inc | 77% | |
| Rapa Therapeutics | 76% |
WindMIL Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2018 | ||||
| Series A | Mar 24, 2016 |
WindMIL Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foxkiser | Series B, Series A |
| Domain Associates | Series B, Series A |
| Kintegral Asset Management | Series B |
| Qiming | Series B |
| Forward Equity Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2018
$33M round led by Qiming
- Mar 24, 2016
$11M round led by Domain Associates.
WindMIL Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WindMIL Therapeutics's valuation, stock price, and market status.
Is WindMIL Therapeutics a public or private company?
WindMIL Therapeutics is a private company.
What is the current stock price of WindMIL Therapeutics?
WindMIL Therapeutics is a private company with no public stock price. Caplight tracks WindMIL Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is WindMIL Therapeutics worth (valuation)?
Valuation information for WindMIL Therapeutics is not publicly available.
Can I buy WindMIL Therapeutics stock?
WindMIL Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WindMIL Therapeutics's last funding round?
WindMIL Therapeutics's most recent funding round was Series B on June 18, 2018.
Who are the main investors in WindMIL Therapeutics?
Key investors in WindMIL Therapeutics include Domain Associates, Qiming.
Will WindMIL Therapeutics IPO soon?
No public IPO plans have been announced for WindMIL Therapeutics.
How can I track WindMIL Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WindMIL Therapeutics's secondary market activity and sign up for updates.